Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of November 1, 2025 • 8:00 PM ET

Date/Time Source News Release
06/23/2023 05:00 PM EDT GlobeNewswire Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting
06/08/2023 08:45 AM EDT GlobeNewswire Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review
04/26/2023 08:35 AM EDT Newsfile Grabar Law Office Investigates Claims on Behalf of Shareholders of Enochian Biosciences Inc. (ENOB)
04/14/2023 08:21 PM EDT Newsfile Grabar Law Office Investigates Claims on Behalf of Shareholders of Enochian Biosciences Inc. (ENOB)
04/03/2023 09:00 AM EDT GlobeNewswire Enochian BioSciences' CEO Letter to Shareholders
03/29/2023 09:00 AM EDT GlobeNewswire Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher
03/13/2023 08:30 AM EDT GlobeNewswire Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements
02/23/2023 04:04 PM EST GlobeNewswire Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022
11/30/2022 05:20 PM EST GlobeNewswire Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
10/24/2022 08:00 AM EDT GlobeNewswire Enochian BioSciences Forges Ahead With Focused Approach, Promising Future
Page

Additional News

As of November 1, 2025 • 8:00 PM ET

Date/Time Source News Release
05/26/2023 09:18 AM EDT SeekingAlpha Stocks facing most buy and sell pressure into Russell rebalancing
03/13/2023 09:41 AM EDT SeekingAlpha Enochian BioSciences regains Nasdaq compliance by filing pending reports
02/23/2023 07:14 PM EST SeekingAlpha Enochian gets Nasdaq listing deficiency notice for not filing 10-Q
10/21/2022 05:11 PM EDT SeekingAlpha Enochian Biosciences receives non-compliance letter from Nasdaq
10/17/2022 01:40 PM EDT SeekingAlpha Enochian stock climbs on US patent for oncology platform
09/24/2022 07:30 PM EDT ACCESSWIRE IA ENOB FINAL DEADLINE MONDAY: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Enochian BioSciences, Inc. Investors to Secure Counsel Before Important September 26 Deadline in Securities Class Action - ENOB
09/22/2022 05:59 PM EDT ACCESSWIRE IA Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Enochian To Contact Him Directly To Discuss Their Options
09/22/2022 02:45 PM EDT ACCESSWIRE IA CLASS ACTION UPDATE for ENOB, TUYA and CODX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
09/21/2022 05:52 PM EDT ACCESSWIRE IA Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Enochian To Contact Him Directly To Discuss Their Options
09/21/2022 09:30 AM EDT ACCESSWIRE IA CLASS ACTION UPDATE for ENOB, CPNG and PLTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.